Polymorphs of N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino]methyl]phenyl]-2E-2-propenamide

Details for Australian Patent Application No. 2007257881 (hide)

Owner Novartis AG

Inventors Slade, Joel; Bajwa, Joginder S.; Stowasser, Frank; Acemoglu, Murat; Papoutsakis, Dimitris; Karpinski, Piotr

Agent Davies Collison Cave

Pub. Number AU-B-2007257881

PCT Pub. Number WO2007/146716

Priority 60/804,517 12.06.06 US; 60/883,224 03.01.07 US

Filing date 7 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 16 June 2011

International Classifications

C07D 209/00 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/146716 Priority application(s): WO2007/146716

16 June 2011 Application Accepted

  Published as AU-B-2007257881

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257882-Process for making salts of N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino]methyl]phenyl]-2E-2-propenamide

2007257870-Method and apparatus for levator distension repair